Ambassador Kenji Hiramatsu attended the “3rd India-Japan Medical Products Regulatory Symposium” and hosted a reception for the delegates

Ambassador Kenji Hiramatsu attended and delivered his address at the opening session of the “3rd India-Japan Medical Products Regulatory Symposium”, co-organized by the Ministry of Health, Labour and Welfare (MHLW) of Japan, Pharmaceuticals and Medical Devices Agency (PMDA) of Japan, Ministry of Health and Family Welfare (MHFW) of India, and Central Drugs Standard Control Organization (CDSCO) of India, on 27th August 2018, at the India Habitat Center. (Address by H.E. Mr. Kenji Hiramatsu, Ambassador of Japan to India)
 
 On the evening of 27th, Ambassador Hiramatsu also hosted a reception at the Ambassador’s Residence, Embassy of Japan, inviting the participants of the symposium, and relevant stakeholders.
 
The symposium has been organized annually, based upon the Memorandum of Cooperation on Pharmaceutical Affairs Regulation Dialogue and Cooperation Framework, which was signed in December 2015.
 
This symposium was held on the 27th and 28th, with the participation of government officials and representatives of medical products industries from both countries.
 
In the event, lectures were given from both countries’ regulators for the outlines and latest trends of the regulations for drugs, medical devices and regenerative medical products, etc., and for best practices from both regulatory authorities and industries. Both countries’ regulators also held a bilateral meeting on 28th August and discussed their collaborations, such as, Japanese contribution to the enhancement of capabilities of Indian regulator, etc.
 
These initiatives will contribute to the improvement of mutual credibility and level of regulations of both countries. Moreover, they will lead to raising the quality of drugs exported from India to Japan, foster appropriate regulatory environment in which Japanese drugs and medical devices industries do business, promoting investments in India by Japanese companies in the healthcare sector.